Evidence map›Paper›PMID 12215904›Full record

ArticleGenes and immunity2002

The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3).

A I Quintero-Del-Rio, J A Kelly, J Kilpatrick, J A James, J B Harley

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.Journal of the American Society of Nephrology : JASN · 2014
    Article
  5. Article
  6. Article
  7. Prevalence of genetic renal disease in children.Pediatric nephrology (Berlin, Germany) · 2013
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Current status of lupus genetics.Arthritis research & therapy · 2007
    Review
  16. Unraveling the genetics of systemic lupus erythematosus.Springer seminars in immunopathology · 2006
    Review
  17. Article
  18. Current advances in the human lupus genetics.Current rheumatology reports · 2004
    Review
  19. Article
  20. T-helper cell tolerance to ubiquitous nuclear antigens.Scandinavian journal of immunology · 2003
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

A I Quintero-Del-RioArthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. ana-quintero@omrf.ouhsc.edu
J A Kelly
J Kilpatrick
J A James
J B Harley
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · USUnited States Department of Veterans Affairs · US

Funding

Y RNA SEQUENCES AND RO RNP FUNCTIONR01AI031584 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1991 to 2006
$2.7M
SPECIALIZED CENTER OF RESEARCH IN SLEP50AR045231 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BEHRENS, TIMOTHY W. · 1998 to 2001
$2.2M
LUPUS MULTIPLEX REGISTRY AND REPOSITORY-264012253N01AR012253 · NIAMS · OKLAHOMA MEDICAL RESEARCH FDN · 2002 to 2005
–
IMMUNOASSAYS FOR PENTAMIDINE LIKE (DICATIONIC) DRUGSR41AI042460 · NIAID · IMMTECH INTERNATIONAL, INC. · PI REISNER, HOWARD M · 1998 to 1998
–
NIAID NIH HHS AI31584NIAID NIH HHS AI42460NIAMS NIH HHS AR-1-2253NIAMS NIH HHS AR24717NIAMS NIH HHS AR45231NIAMS NIH HHS AR52221
6 · The paper itself

Abstract

Renal disease occurs in 40-75% of systemic lupus erythematosus (SLE) patients and significantly contributes to morbidity and mortality. We used two pedigree stratification strategies to explore the impact of the ACR renal criterion for SLE classification upon genetic linkage with SLE. In both we used SLE as the phenotype. First, we evaluated genome scan data from >300 microsatellite markers in the 75 pedigrees that had at least one SLE affected with the SLE renal criterion. A maximum-likelihood parametric model approach produced a maximum screening LOD score of 3.16 at 10q22.3 in the European-American (EA) pedigrees. The African-American (AA) pedigrees obtained a maximum screening LOD score of 2.58 at 11p15.6. A multipoint sib-pair regression analysis produced P = 0.0000008 in EA at 10q22.3 (SLEN1) and P = 0.000001 in AA at 2q34-35 (SLEN2). A second stratification strategy explored the renal criterion in 35 pedigrees with two or more SLE patients with renal disease and produced a LOD score of 3.34 at 11p15.6 in AA (SLEN3). Sib-pair analysis in these 35 pedigrees revealed P = 0.00003 at 4q13.1 in EA, P = 0.00003 at 11p13 and 0.00007 at 3q23 in AA. Thus, multiple genetic linkages are related to the renal criterion in SLE. Of the significant genetic linkages with SLE described herein, those at 10q22.3 in the EA pedigrees (SLEN1) and at 2q34-35 in the AA pedigrees (SLEN2) have not been previously described.

Indexed as

Genetic LinkageBlack or African AmericanBlack PeopleChromosomes, Human, Pair 10Chromosomes, Human, Pair 11Chromosomes, Human, Pair 2FemaleHumansLod ScoreLupus Erythematosus, SystemicMaleNephritisPedigreeWhite People

Identifiers

PMID12215904
OpenAlexW2003456414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.